about
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer.High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study.Alectinib for ALK-positive non-small-cell lung cancer.Developments in pharmacotherapy for treating metastatic non-small cell lung cancer.A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.Anti-cancer Effects of Polyphenolic Compounds in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.PPARγ sumoylation-mediated lipid accumulation in lung cancer.New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.Oncogene-Driven Metabolic Alterations in Cancer.Local Intratracheal Delivery of Perfluorocarbon Nanoparticles to Lung Cancer Demonstrated with Magnetic Resonance Multimodal Imaging.Olmutinib: First Global Approval.Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer.TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis.Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor.GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.The state of the art in the development of a panel of biomarkers for the early detection of lung cancer.Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.Hub genes and key pathways of non-small lung cancer identified using bioinformatics.Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancerPembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expressionReal-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
P2860
Q38703087-636F2879-BAA0-4A9C-8530-0BC1339C863CQ38742396-3C6664AA-CDFE-4B8C-8920-E990B05E3313Q38840279-715ED145-3651-4F39-B071-49A29811ED14Q38846027-F957CE37-6619-4AAF-8253-C8DBE026BE9FQ39076364-C6DC5E86-E0B1-4C57-B64F-A00A9BFF5EBBQ42176799-2B8A15DC-C92E-4811-89DE-5A244D92FA0FQ43987893-9C136A16-8268-4FB3-9281-2AC57A6E2609Q44646012-9D5FE109-F0F2-40A1-8E52-3FB0D3D2509EQ46248958-12E1452E-089A-4D33-9935-8D42B2C69AC1Q46261446-C886805E-A3EF-4557-BED7-77F7A5257CDDQ47159366-066DF631-D816-4029-912B-413711C95EF6Q47159555-1AF1F1C5-FC48-45C5-A0C4-77BEE434F1FFQ47269748-2BF293DB-AFA2-4C4A-8F24-6334B2B4C4CAQ51673799-73F9446D-A2B2-43BB-9D00-55805C8C15C8Q52599930-F7C4029E-3662-428A-A7DE-C42542E8788BQ52626559-5CCA8A38-965B-4D5D-8EAA-02AC1ECD50C5Q53078264-1F07DA78-8A23-426E-863B-E301DD7C9AB0Q54945156-C7A23D48-7F1A-4C6D-9974-C00E6580CC84Q55016891-EC1C62B2-966B-4B3E-98A8-FDED5084BCC6Q55070093-023C7564-CAD5-4BA0-A780-D14CF57002E2Q55625808-B39847C3-C538-4D56-B0A2-C51F3162FB11Q58714045-F814836C-72AC-406D-9C07-B3A1665DEAF6Q58759053-F1746E31-BEC3-48FE-986D-C357570BF33AQ59137536-5BD732C3-9234-4FC6-9A81-DBDA7BE19B41
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Non-small-cell lung cancer.
@en
type
label
Non-small-cell lung cancer.
@en
prefLabel
Non-small-cell lung cancer.
@en
P2093
P2860
P50
P356
P1476
Non-small-cell lung cancer.
@en
P2093
Antonio Rossi
David P Carbone
Niki Karachaliou
P2860
P2888
P356
10.1038/NRDP.2015.9
P577
2015-05-21T00:00:00Z